HAIFA, Israel, January 19, 2021 / PRNewswire / – MindUP, Israel The first dedicated digital health incubator is excited to welcome CogMe to its family of portfolio companies.
CogMe is developing a platform to reduce cognitive decline in at-risk populations, with an initial focus on delirium, an acute illness that is most common in hospital settings. Using AI, CogMe offers a comprehensive solution that analyzes cognitive and biological indicators of the individual patient to predict, detect and intervene in cognitive drops.
“Delirium, a widespread and dangerous state of sudden confusion that is common in older adults, is underestimated and under-treated almost everywhere,” he noted Liat Feinberg, CEO and Co-Founder of CogMe. “It often leads to a cascade of events that include patient falls, additional complications, advanced post-acute care, and even death. Obviously, these adverse events also add to the cost of care. We believe that early detection is key to prevention this is deterioration. “
And Shwarzman, CEO of MindUP, said, “CogMe will offer a scalable and sustainable holistic solution to help healthcare providers predict the patient’s condition and take prompt action to prevent these cognitive dips. We enjoy a strong team such as co-founders Liat Feinberg and Ilan Ben-Oren Join MindUP. “
MindUP, Israel The first dedicated digital health incubator is a joint venture between Medtronic, IBM, Pitango Venture Capital, Impact First Investments and Rambam Medical Center in partnership with the Israel Innovation Authority. MindUP finances, supports and promotes early-stage digital health projects. MindUP offers its portfolio companies a platform that offers 360-degree support for all of their requirements and significantly increases their chances of success.
To learn more: